HOME >> MEDICINE >> NEWS
Express Scripts 1999 drug trend report: Seniors hit hardest by record 17.4-Percent prescription drug spending increase

nts in the pharmaceutical landscape. Conference attendees are also learning how cost increases can be significantly lowered by proactively managing the pharmacy benefit; some Express Scripts clients that actively manage their pharmacy benefit program have actually cut their trend in half.

The Express Scripts 1999 Drug Trend Report showed that price increases were a major factor, accounting for nearly a third of the hike in drug spending. The top 50 common branded drugs, ranked by prescriptions filled, had price increases from zero to 15.6 percent between 1998 and 1999.

New drugs played a small but significant role last year, due to the unprecedented rapid adoption of the COX-II anti-rheumatic medications Searle's Celebrex and Merck's Vioxx. "Typically, the cost impact of new drugs is initially felt in the second or third years after their introduction, but these drugs clearly were exceptions last year," explained Toan.

"As we look to the future, new drugs are expected to play an even greater role in future cost acceleration as the Human Genome Project draws toward completion," said Toan, noting that the genome project already is contributing to a remarkable acceleration of drug discovery. According to the Express Scripts 1999 Drug Trend Report, "The number and therapeutic promise of such innovations are exciting. However, the cost of these technological advances will likely be high."

Common drug utilization, which most closely reflects the impact of direct-to-consumer advertising, once again played a major role in the overall cost increase, nearly doubling in its impact on the total spending increase to 6.2 percent in 1999 from 3.8 percent in 1998. "Unlike price increases, which seemed to affect all drug classes broadly, the impact of increased utilization was concentrated in the most popular therapy classes. Americans are using more of the drugs they already use the most," said Toan. The biggest cost-increase impact due to greater utiliza
'"/>

Contact: Ryan Soderstrom
rsoderst@express-scripts.com
612-837-5160
Kupper Parker Communications
26-Jun-2000


Page: 1 2 3 4

Related medicine news :

1. New evidence about positive three-tier co-pay performance presented at Express Scripts 2000 Outcomes Conference
2. Tracking trends in cochlear implant complications using a federal database
3. Changing trends in herbal supplement use
4. New figures highlight trends in drug and alcohol misuse
5. Study of trends in celiac disease
6. Different approaches required for monitoring suicide trends
7. Screening for depression at primary level could be next trend in healthcare
8. Study identifies trends in self-referred imaging
9. First quarter prescription drug spending: Generic drugs slow upward trend
10. Why trends in stroke death in 20th century appeared different to death from heart disease
11. CDC reports latest syphilis trends in United States

Post Your Comments:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
(Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & ... and Drug Administration (FDA) has accepted for Priority ... as a treatment for patients with multiple myeloma ... (PI) and an immunomodulatory agent (IMiD), or who ... therapy, including a PI and an IMiD. This ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
(Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 /PRNewswire/ ... Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) ... key opinion leaders, and thought leaders in critical ... effectiveness of their field-based teams, companies are expanding ... order to align countries with corporate objectives and ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2
Cached News: